BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0 London, UK, 27 February 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announced U.S. Food and Drug ...

Ekos, a Bothell medical device maker whose catheter-based ultrasound devices are used to break up blood clots in legs, has been acquired by British pharmaceutical company BTG for $180 million. The ...

(ShareCast News) - Medical products group BTG grew sales at double-digits at constant exchange rates in the first half of the year and confirmed it was on track for the full year, while also ...

BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the OPTALYSE PE trial, presented at the American Thoracic Society ...

BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how ...

BTG plc (BTG or the Company), the specialist healthcare company, is pleased to announce that it has entered into an agreement to buy EKOS Corporation (EKOS) a fast growing and profitable ...

Add Yahoo as a preferred source to see more of our stories on Google. LONDON (Reuters) - British pharmaceutical firm BTG said on Monday its EKOS combination therapy device for pulmonary embolism (PE) ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — In patients with acute submassive pulmonary embolism, treatment with tissue plasminogen ...

LONDON, May 22 (Reuters) - British pharmaceutical firm BTG said on Monday its EKOS combination therapy device for pulmonary embolism (PE) was effective using smaller drug dosages and shorter treatment ...